Last reviewed · How we verify

NCT05411003

Urdu Version Of Nottingham Extended Activities Of Daily Living Scale: Reliability And Validity Study

Completed Last updated 7 May 2024
What this trial tests

trial in Stroke in 80 participants. Completed in 12 July 2023.

Timeline
30 May 2021
Primary endpoint
10 July 2023
12 July 2023

Quick facts

Lead sponsorRiphah International University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date30 May 2021
Primary completion10 July 2023
Estimated completion12 July 2023
Sites1 location across Pakistan

Conditions studied

Sponsor

Riphah International University

Who can join

67 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to know the validity and reliability as well as to translate and culturally adapt the Nottingham Extended Activities Of Daily Living Scale into Urdu language in Pakistani population of Stroke. This study also aims to correlate the scale with the Modified Barthel Index and Frenchay Activities Index.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05411003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing